(Q45767503)

15 December 2017

title

Pharmacokinetics of hydroxyurea in patients infected with human immunodeficiency virus type I. (English)

1 reference

15 December 2017

1 reference

1 reference

Villani P

1

1 reference

15 December 2017

Maserati R

2

1 reference

15 December 2017

Regazzi MB

3

1 reference

15 December 2017

Giacchino R

4

1 reference

15 December 2017

Lori F

5

1 reference

15 December 2017

publication date

1 February 1996

1 reference

15 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

15 December 2017

volume

36

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

117-121

1 reference

15 December 2017

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04176.X

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04176.X

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04176.X

Suppression of HIV production in resting lymphocytes by combining didanosine and hydroxamate compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04176.X

Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04176.X

10.1002/J.1552-4604.1996.TB04176.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017